Essential Hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 40 to 65 years; diagnosis of essential hypertension; adherence to the treatment confirmed; blood pressure of at least 140 to 85 mmHg despite treatment with three anti-hypertensive drugs; blood pressure less than 130 to 85 with the use of four or more antihypertensive drugs.
Exclusion criteria
Exclusion criteria: Secondary hypertension; diabetes mellitus; stage III, IV and V chronic kidney disease; coronary artery disease; cerebrovascular disease; hepatic insufficiency; ophthalmologic disorders; regular use of nitric oxide donor drugs; stimulators of guanylate cyclase; pregnancy or lactation; current abuse of alcohol or other drugs; severe past drug allergy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of vascular and hemostatic response to mental stress in patients with resistant hypertension; verified by decreased flow-mediated dilatation, pulse wave velocity, coagulation markers and increased bioavailability of nitric oxide; from the observation of a p value less than or equal to 0.05 in the comparisons of the pre- and post-intervention measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference in the behavior of vascular variables and hemostatic to mental stress among men and women with resistant hypertension; verified by measurements of flow-mediated dilatation, pulse wave velocity, coagulation markers, and bioavailability of nitric oxide; from the observation of a p value less than or equal to 0.05 in the comparisons of the pre- and post-intervention measurements. | — |
Countries
Brazil
Contacts
Universidade Federal Fluminense